Translation to the Clinic: Role of Preclinical Models & Biomarkers to Optimize Dry AMD Clinical Trials

Time: 8:00 am
day: Day Two


  • Translatability and considerations of preclinical models for dry AMD
  • Lessons learned from the clinic – how can we maximally de-risk preclinical assets prior to initiation of clinical trials?
  • Role of molecular and imaging biomarkers for early POC clinical trials